Calcium Channel TRPV6 as a Potential Therapeutic Target in Estrogen Receptor-Negative Breast Cancer

Amelia A. Peters, Peter T. Simpson, Johnathon J. Bassett, Jane M. Lee, Leonard Da Silva, Lynne E. Reid, Sarah Song, Marie Odile Parat, Sunil R. Lakhani, Paraic A. Kenny, Sarah J. Roberts-Thomson, Gregory R. Monteith

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Calcium signaling is a critical regulator of cell proliferation. Elevated expression of calcium channels and pumps is a characteristic of some cancers, including breast cancer. We show that the plasma membrane calcium channel TRPV6, which is highly selective for Ca2+, is overexpressed in some breast cancer cell lines. Silencing of TRPV6 expression in a breast cancer cell line with increased endogenous TRPV6 expression leads to a reduction in basal calcium influx and cellular proliferation associated with a reduction in DNA synthesis. TRPV6 gene amplification was identified as one mechanism of TRPV6 overexpression in a subset of breast cancer cell lines and breast tumor samples. Analysis of two independent microarray expression datasets from breast tumor samples showed that increased TRPV6 expression is a feature of estrogen receptor (ER)-negative breast tumors encompassing the basal-like molecular subtype, as well as HER2-positive tumors. Breast cancer patients with high TRPV6 levels had decreased survival compared with patients with low or intermediate TRPV6 expression. Our findings suggest that inhibitors of TRPV6 may offer a novel therapeutic strategy for the treatment of ER-negative breast cancers.

Original languageEnglish (US)
Pages (from-to)2158-2168
Number of pages11
JournalMolecular Cancer Therapeutics
Volume11
Issue number10
DOIs
StatePublished - Oct 2012

Fingerprint

Calcium Channels
Estrogen Receptors
Breast Neoplasms
Therapeutics
Cell Line
Cell Proliferation
Calcium Signaling
Gene Amplification
Ion Channels
Cell Membrane
Calcium
Survival
DNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Peters, A. A., Simpson, P. T., Bassett, J. J., Lee, J. M., Da Silva, L., Reid, L. E., ... Monteith, G. R. (2012). Calcium Channel TRPV6 as a Potential Therapeutic Target in Estrogen Receptor-Negative Breast Cancer. Molecular Cancer Therapeutics, 11(10), 2158-2168. https://doi.org/10.1158/1535-7163.MCT-11-0965

Calcium Channel TRPV6 as a Potential Therapeutic Target in Estrogen Receptor-Negative Breast Cancer. / Peters, Amelia A.; Simpson, Peter T.; Bassett, Johnathon J.; Lee, Jane M.; Da Silva, Leonard; Reid, Lynne E.; Song, Sarah; Parat, Marie Odile; Lakhani, Sunil R.; Kenny, Paraic A.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.

In: Molecular Cancer Therapeutics, Vol. 11, No. 10, 10.2012, p. 2158-2168.

Research output: Contribution to journalArticle

Peters, AA, Simpson, PT, Bassett, JJ, Lee, JM, Da Silva, L, Reid, LE, Song, S, Parat, MO, Lakhani, SR, Kenny, PA, Roberts-Thomson, SJ & Monteith, GR 2012, 'Calcium Channel TRPV6 as a Potential Therapeutic Target in Estrogen Receptor-Negative Breast Cancer', Molecular Cancer Therapeutics, vol. 11, no. 10, pp. 2158-2168. https://doi.org/10.1158/1535-7163.MCT-11-0965
Peters, Amelia A. ; Simpson, Peter T. ; Bassett, Johnathon J. ; Lee, Jane M. ; Da Silva, Leonard ; Reid, Lynne E. ; Song, Sarah ; Parat, Marie Odile ; Lakhani, Sunil R. ; Kenny, Paraic A. ; Roberts-Thomson, Sarah J. ; Monteith, Gregory R. / Calcium Channel TRPV6 as a Potential Therapeutic Target in Estrogen Receptor-Negative Breast Cancer. In: Molecular Cancer Therapeutics. 2012 ; Vol. 11, No. 10. pp. 2158-2168.
@article{a3e39fa0b93a4ff59f44a1169fac2280,
title = "Calcium Channel TRPV6 as a Potential Therapeutic Target in Estrogen Receptor-Negative Breast Cancer",
abstract = "Calcium signaling is a critical regulator of cell proliferation. Elevated expression of calcium channels and pumps is a characteristic of some cancers, including breast cancer. We show that the plasma membrane calcium channel TRPV6, which is highly selective for Ca2+, is overexpressed in some breast cancer cell lines. Silencing of TRPV6 expression in a breast cancer cell line with increased endogenous TRPV6 expression leads to a reduction in basal calcium influx and cellular proliferation associated with a reduction in DNA synthesis. TRPV6 gene amplification was identified as one mechanism of TRPV6 overexpression in a subset of breast cancer cell lines and breast tumor samples. Analysis of two independent microarray expression datasets from breast tumor samples showed that increased TRPV6 expression is a feature of estrogen receptor (ER)-negative breast tumors encompassing the basal-like molecular subtype, as well as HER2-positive tumors. Breast cancer patients with high TRPV6 levels had decreased survival compared with patients with low or intermediate TRPV6 expression. Our findings suggest that inhibitors of TRPV6 may offer a novel therapeutic strategy for the treatment of ER-negative breast cancers.",
author = "Peters, {Amelia A.} and Simpson, {Peter T.} and Bassett, {Johnathon J.} and Lee, {Jane M.} and {Da Silva}, Leonard and Reid, {Lynne E.} and Sarah Song and Parat, {Marie Odile} and Lakhani, {Sunil R.} and Kenny, {Paraic A.} and Roberts-Thomson, {Sarah J.} and Monteith, {Gregory R.}",
year = "2012",
month = "10",
doi = "10.1158/1535-7163.MCT-11-0965",
language = "English (US)",
volume = "11",
pages = "2158--2168",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Calcium Channel TRPV6 as a Potential Therapeutic Target in Estrogen Receptor-Negative Breast Cancer

AU - Peters, Amelia A.

AU - Simpson, Peter T.

AU - Bassett, Johnathon J.

AU - Lee, Jane M.

AU - Da Silva, Leonard

AU - Reid, Lynne E.

AU - Song, Sarah

AU - Parat, Marie Odile

AU - Lakhani, Sunil R.

AU - Kenny, Paraic A.

AU - Roberts-Thomson, Sarah J.

AU - Monteith, Gregory R.

PY - 2012/10

Y1 - 2012/10

N2 - Calcium signaling is a critical regulator of cell proliferation. Elevated expression of calcium channels and pumps is a characteristic of some cancers, including breast cancer. We show that the plasma membrane calcium channel TRPV6, which is highly selective for Ca2+, is overexpressed in some breast cancer cell lines. Silencing of TRPV6 expression in a breast cancer cell line with increased endogenous TRPV6 expression leads to a reduction in basal calcium influx and cellular proliferation associated with a reduction in DNA synthesis. TRPV6 gene amplification was identified as one mechanism of TRPV6 overexpression in a subset of breast cancer cell lines and breast tumor samples. Analysis of two independent microarray expression datasets from breast tumor samples showed that increased TRPV6 expression is a feature of estrogen receptor (ER)-negative breast tumors encompassing the basal-like molecular subtype, as well as HER2-positive tumors. Breast cancer patients with high TRPV6 levels had decreased survival compared with patients with low or intermediate TRPV6 expression. Our findings suggest that inhibitors of TRPV6 may offer a novel therapeutic strategy for the treatment of ER-negative breast cancers.

AB - Calcium signaling is a critical regulator of cell proliferation. Elevated expression of calcium channels and pumps is a characteristic of some cancers, including breast cancer. We show that the plasma membrane calcium channel TRPV6, which is highly selective for Ca2+, is overexpressed in some breast cancer cell lines. Silencing of TRPV6 expression in a breast cancer cell line with increased endogenous TRPV6 expression leads to a reduction in basal calcium influx and cellular proliferation associated with a reduction in DNA synthesis. TRPV6 gene amplification was identified as one mechanism of TRPV6 overexpression in a subset of breast cancer cell lines and breast tumor samples. Analysis of two independent microarray expression datasets from breast tumor samples showed that increased TRPV6 expression is a feature of estrogen receptor (ER)-negative breast tumors encompassing the basal-like molecular subtype, as well as HER2-positive tumors. Breast cancer patients with high TRPV6 levels had decreased survival compared with patients with low or intermediate TRPV6 expression. Our findings suggest that inhibitors of TRPV6 may offer a novel therapeutic strategy for the treatment of ER-negative breast cancers.

UR - http://www.scopus.com/inward/record.url?scp=84867415114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867415114&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-11-0965

DO - 10.1158/1535-7163.MCT-11-0965

M3 - Article

C2 - 22807578

AN - SCOPUS:84867415114

VL - 11

SP - 2158

EP - 2168

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 10

ER -